Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome

Abstract

Abstract. Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder that considerably reduces quality of life and is an economic burden on society. The pathogenesis of IBS is unknown. However, intestinal low-grade inflammation has been proposed as one of the factors contributing to the development of IBS. The present study aimed to examine the possible occurrence of low-grade inflammation in the rectum of patients with sporadic IBS. In total, 50 patients (42 females and 8 males with an average age of 34 years) with sporadic IBS fulfilling the Rome III Criteria were recruited for this study. Of these, 30 patients had IBS with diarrhoea as the predominant symptom (IBS-D) and 20 patients had IBS with constipation as the predominant symptom (IBS-C). A total of 27 control subjects (19 females and 8 males with an average age of 53 years) were included. The patients and controls underwent colonoscopy with rectal biopsies. The biopsies were immunostained for total leucocytes, lymphocytes, monocytes, macrophages and mast cells. The mucosal density of these cells was quantified by computer image analysis. The number of intraepithelial leucocytes and the density of the leucocytes in the lamina propria of the IBS patients did not differ from that of the controls. Similarly, there was no difference in the cell density of the mast cells in the lamina propria between the patients and the controls. The numbers of mucosal lymphocytes, macrophages and monocytes were low in the patients and the controls. These findings oppose low-grade inflammation as a pathogenic factor in sporadic IBS. Low-grade inflammation may, however, play an important role in the pathogenesis of a subset of IBS, namely post-infectious IBS (PI-IBS).

Colonic immune cells in irritable bowel syndrome: A systematic review and meta‐analysis

“…Twenty‐two studies which analyzed colonic mast cell and/or lymphocyte counts were included in this meta‐analysis . The studies included a total of 706 patients with IBS and 401 controls.…”

“…The above mentioned physiological balance is affected in GI diseases/disorders such as IBS. Higher mast cell and T cell mucosal infiltration, their state of activity, and cytokine secretion and gene polymorphisms have been proposed to impact bowel physiology and participate in symptom development of IBS . However, these results remain controversial.…”

Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators

“…In all, 66 articles were identified that provided results on either mucosal or serological immune markers in IBS; 43 reported on mucosal changes, 19 on serological markers and seven on both. Some focused on specific IBS subtypes, including three reported on a comparison of diarrhea‐predominant IBS (IBS‐D) with healthy controls, one compared post‐infection (PI)‐IBS to the general population, and three limited their evaluation to a comparison between PI‐IBS and IBS‐D .…”

Irritable bowel syndrome: Emerging paradigm in pathophysiology

“…El-Salhy et al [71] reported that rectal biopsy specimens taken from patient after Campylobacter gastroenteritis showed increases in leucocytes, lymphocytes, mast cells and endocrine cells. Another study reported that 3 mo post-gastroenteritis, patients who had PI-IBS continued to increase their chronic inflammatory cell counts, while those in healthy controls returned to normal levels [72] .…”